GB SCIENCES News and Stock Quote (OTCMKTS: GBLX) - Green Stock News

Login
LOG IN / REGISTER

MOD_LOGIN_SOCIALNETWORKS_OR

MOD_LOGIN_SOCIALNETWORKS_OR

BevCanna Enterprises

GB SCIENCES OTCMKTSGBLX STOCK QUOTE

https://gbsciences.com/

LATEST NEWS FROM GB SCIENCES

September 14, 2021

Gb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndrome Therapies Designed to Suppress COVID-Related Hyperinflammation

September 9, 2021

Gb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C. Wainwright's 23rd Annual Global Investment Conference

August 10, 2021

Gb Sciences to Present at the SNN Network Summer Virtual Event on Wednesday, August 18th, 2021

July 27, 2021

GB Sciences Is Developing Plant-Inspired Mixtures for Anxiety, Depression, and Pain From PhAROS, GB Sciences' Proprietary AI-Accelerated Drug Discovery Platform

June 29, 2021

GB Sciences Using AI Technology in Plant-Based Drug Discovery Research

June 17, 2021

GB Sciences' Board of Directors Has Passed a Unanimous Written Consent Promoting Dr. Andrea Small-Howard to the Role of President

April 20, 2021

GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals

April 7, 2021

GB Sciences Files Provisional Patent Application to Protect Its Proprietary Drug Discovery Platform

March 23, 2021

GB Sciences Publishes Study on Creation of Novel Terpene-Containing Nanoparticles for Pain Relief